Association of Life's Essential 8 and Life's Simple 7 with metabolic-associated fatty liver disease in the United States

被引:1
|
作者
Fu, Wei [1 ]
Cheng, Guo-Bin [2 ]
Zhao, Jun-Long [3 ]
Lv, Lin-Ya [2 ]
Ding, Yao [2 ]
机构
[1] 925 PLA, Dept Gastroenterol, 67 Huanghelu, Guiyang 550009, Guizhou, Peoples R China
[2] 925 Hosp PLA Joint Logist Support Force, Dept Gastroenterol, Guiyang 550009, Guizhou, Peoples R China
[3] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China
关键词
Cardiovascular health; Life's Essential 8; Life's Simple 7; Metabolic-associated fatty liver disease; National Health And Nutrition Examination Survey; AMERICAN HEART ASSOCIATIONS;
D O I
10.4254/wjh.v17.i2.97741
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Cardiovascular health (CVH) plays a crucial role in overall health, but its association with metabolic-associated fatty liver disease (MAFLD) remains unclear. AIM To investigate the relationship between CVH, measured using Life's Essential 8 (LE8) and Life's Simple 7 (LS7), and the prevalence of MAFLD. METHODS This cross-sectional study had a sample of 2234 individuals, representing approximately 120 million individuals in the United States. Baseline parameters were compared between the LE8 and LS7 groups. Logistic regression models were used to evaluate the relationship between LE8, LS7, and MAFLD, while taking into account confounding factors. The investigation employed restricted cubic splines to investigate non-linear associations. Subgroup analyses and sensitivity studies were performed to evaluate the strength and reliability of the results. RESULTS Higher LE8 and LS7 scores were significantly associated with a decreased risk of MAFLD, even after controlling for demographic, socioeconomic, and clinical variables. This association demonstrated a non-linear pattern, with the most dramatic risk reduction observed at higher CVH levels. Individual CVH components, notably healthy behaviors and factors, exhibited strong relationships with MAFLD. Subgroup analyses indicated consistent relationships across several demographics. Sensitivity tests utilizing other MAFLD definitions validated the robustness of the findings. CONCLUSION Higher adherence to CVH criteria, as indicated by LE8 and LS7 scores, is associated with a significantly lower risk of MAFLD. These results emphasize the need to advance CVH to control and avoid MAFLD.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Life's essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
    Zhang, Yingying
    Wang, Pingping
    Tu, Fan
    Kang, Hao
    Fu, Chengfeng
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [2] Association between life's essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults
    Wang, Zheng
    Huang, Bohan
    Ding, Yixuan
    Cao, Feng
    Li, Fei
    Li, Prof Fei
    ARCHIVES OF PUBLIC HEALTH, 2024, 82 (01)
  • [3] Association of life's essential 8 with all-cause and cause-specific mortality in metabolic dysfunction-associated steatotic liver disease
    Li, Xiang
    Zhang, Yi
    Gong, Junyi
    Ni, Xiang
    Yin, Junli
    Lv, Zheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
    Bae, Jaehyun
    Lee, Byung-Wan
    BIOMOLECULES, 2023, 13 (10)
  • [5] Alcohol and Metabolic-associated Fatty Liver Disease
    Sun, Fu-Rong
    Wang, Bing-Yuan
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (05) : 719 - 730
  • [6] Pathobiology of Metabolic-Associated Fatty Liver Disease
    Fouda, Sherouk
    Jeeyavudeen, Mohammed Sadiq
    Pappachan, Joseph M.
    Jayanthi, Venkataraman
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 405 - 416
  • [7] Cardiovascular disease in metabolic-associated fatty liver disease
    Adams, Leon A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (02) : 81 - 86
  • [8] Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease
    Jamali, Raika
    Veisi, Soroush
    Jamali, Arsia
    Yaseri, Mehdi
    HEPATITIS MONTHLY, 2022, 22 (01)
  • [9] Metabolic-Associated Fatty Liver Disease and the Gut Microbiota
    Barber, Thomas M.
    Hanson, Petra
    Weickert, Martin O.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 485 - 496
  • [10] Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence
    Vespoli, Carolyn
    Iqbal, Anoop Mohamed
    Kabbany, Mohammad Nasser
    Radhakrishnan, Kadakkal
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 417 - 430